Literature DB >> 33496291

Asymmetric organocatalysis: an enabling technology for medicinal chemistry.

Bo Han1, Xiang-Hong He1, Yan-Qing Liu1, Gu He2, Cheng Peng1, Jun-Long Li3.   

Abstract

The efficacy and synthetic versatility of asymmetric organocatalysis have contributed enormously to the field of organic synthesis since the early 2000s. As asymmetric organocatalytic methods mature, they have extended beyond the academia and undergone scale-up for the production of chiral drugs, natural products, and enantiomerically enriched bioactive molecules. This review provides a comprehensive overview of the applications of asymmetric organocatalysis in medicinal chemistry. A general picture of asymmetric organocatalytic strategies in medicinal chemistry is firstly presented, and the specific applications of these strategies in pharmaceutical synthesis are systematically described, with a focus on the preparation of antiviral, anticancer, neuroprotective, cardiovascular, antibacterial, and antiparasitic agents, as well as several miscellaneous bioactive agents. The review concludes with a discussion of the challenges, limitations and future prospects for organocatalytic asymmetric synthesis of medicinally valuable compounds.

Mesh:

Substances:

Year:  2021        PMID: 33496291     DOI: 10.1039/d0cs00196a

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  12 in total

Review 1.  Synthesis and Applications of Carbohydrate-Based Organocatalysts.

Authors:  Elżbieta Wojaczyńska; Franz Steppeler; Dominika Iwan; Marie-Christine Scherrmann; Alberto Marra
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

2.  Tunable and Cooperative Catalysis for Enantioselective Pictet-Spengler Reaction with Varied Nitrogen-Containing Heterocyclic Carboxaldehydes.

Authors:  Yuk-Cheung Chan; Marcus H Sak; Scott A Frank; Scott J Miller
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-07       Impact factor: 15.336

Review 3.  Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.

Authors:  Rui Qin; Feng-Ming You; Qian Zhao; Xin Xie; Cheng Peng; Gu Zhan; Bo Han
Journal:  J Hematol Oncol       Date:  2022-09-14       Impact factor: 23.168

4.  Synthesis of Highly Congested Tertiary Alcohols via the [3,3] Radical Deconstruction of Breslow Intermediates.

Authors:  Roger Machín Rivera; Nikolas R Burton; Luke D Call; Marshall A Tomat; Vincent N G Lindsay
Journal:  Org Lett       Date:  2022-06-03       Impact factor: 6.072

5.  3-(((1S,3S)-3-((R)-Hydroxy(4-(trifluoromethyl)phenyl)methyl)-4-oxocyclohexyl)methyl)pentane-2,4-dione: Design and Synthesis of New Stereopure Multi-Target Antidiabetic Agent.

Authors:  Abdul Sadiq; Mater H Mahnashi; Umer Rashid; Muhammad Saeed Jan; Mohammed Abdulrahman Alshahrani; Mohammed A Huneif
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

6.  Organobase-catalyzed 1,1-diborylation of terminal alkynes under metal-free conditions.

Authors:  Junchen Li; Min An; Zhenhua Gao; Yongbiao Guo; Haibo Liu; Peichao Zhao; Xiaojing Bi; Enxue Shi; Junhua Xiao
Journal:  RSC Adv       Date:  2022-06-01       Impact factor: 4.036

7.  Computational Study of the Stability of Pyrrolidine-Derived Iminium Ions: Exchange Equilibria between Iminium Ions and Carbonyl Compounds.

Authors:  Anna M Costa; Víctor Cascales; Alejandro Castro-Alvarez; Jaume Vilarrasa
Journal:  ACS Omega       Date:  2022-05-26

8.  Phosphine-Catalyzed Dearomative [3 + 2] Cycloaddition of Benzoxazoles with a Cyclopropenone.

Authors:  Xingben Wang; Congjun Yu; Iuliana L Atodiresei; Frederic W Patureau
Journal:  Org Lett       Date:  2022-01-27       Impact factor: 6.005

9.  Fast MacMillan's Imidazolidinone-Catalyzed Enantioselective Synthesis of Polyfunctionalized 4-Isoxazoline Scaffolds.

Authors:  Dario Corbisiero; Tommaso Fantoni; Lucia Ferrazzano; Giulia Martelli; Paolo Cantelmi; Alexia Mattellone; Chiara Palladino; Magda Monari; Riccardo Pedrazzani; Alessandra Tolomelli; Walter Cabri
Journal:  ACS Omega       Date:  2022-07-20

10.  Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity.

Authors:  Qian Zhao; Shan-Shan Xiong; Can Chen; Hong-Ping Zhu; Xin Xie; Cheng Peng; Gu He; Bo Han
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.